Frank Takkinen
Stock Analyst at Lake Street
(1.11)
# 3,901
Out of 5,237 analysts
79
Total ratings
32.39%
Success rate
-13.78%
Average return
Main Sectors:
Stocks Rated by Frank Takkinen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AXGN Axogen | Maintains: Buy | $40 → $50 | $40.81 | +22.52% | 3 | Apr 23, 2026 | |
| SMTI Sanara MedTech | Initiates: Buy | $32 | $17.87 | +79.07% | 1 | Apr 15, 2026 | |
| TELA TELA Bio | Maintains: Buy | $3 → $2 | $0.98 | +103.29% | 4 | Mar 25, 2026 | |
| HYPR Hyperfine | Maintains: Buy | $2 → $2.5 | $1.76 | +42.05% | 3 | Mar 19, 2026 | |
| TNDM Tandem Diabetes Care | Upgrades: Buy | $50 | $14.77 | +238.64% | 1 | Feb 23, 2026 | |
| NOTV Inotiv | Maintains: Buy | $3 → $1.5 | $0.29 | +410.90% | 9 | Feb 10, 2026 | |
| RCEL AVITA Medical | Maintains: Hold | $3 → $3.5 | $4.37 | -19.91% | 2 | Jan 16, 2026 | |
| BBNX Beta Bionics | Maintains: Buy | $35 → $40 | $9.83 | +306.92% | 2 | Jan 9, 2026 | |
| KRMD KORU Medical Systems | Maintains: Buy | $6 → $8 | $4.01 | +99.50% | 3 | Dec 22, 2025 | |
| SGHT Sight Sciences | Maintains: Buy | $7 → $12 | $5.32 | +125.78% | 7 | Dec 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $0.95 | +321.32% | 1 | Dec 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $4 | $1.29 | +210.08% | 3 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $6 | $1.05 | +471.43% | 4 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $270 → $150 | $43.35 | +246.02% | 2 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $10.83 | +121.61% | 1 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $14 | $6.90 | +102.90% | 7 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $16 → $15 | $5.74 | +161.32% | 2 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $26 | $13.02 | +99.69% | 3 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $30 | $12.33 | +143.31% | 4 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $6.52 | +206.75% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.26 | +296.83% | 1 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $30 | $23.78 | +26.18% | 2 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $6 | $0.64 | +831.68% | 2 | Apr 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $1.87 | +113.90% | 2 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $15.64 | -23.27% | 2 | Dec 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $9 | $3.90 | +130.77% | 3 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $16 | $4.17 | +283.69% | 2 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $923 → $277 | $6.77 | +3,990.10% | 2 | Jan 18, 2023 |
Axogen
Apr 23, 2026
Maintains: Buy
Price Target: $40 → $50
Current: $40.81
Upside: +22.52%
Sanara MedTech
Apr 15, 2026
Initiates: Buy
Price Target: $32
Current: $17.87
Upside: +79.07%
TELA Bio
Mar 25, 2026
Maintains: Buy
Price Target: $3 → $2
Current: $0.98
Upside: +103.29%
Hyperfine
Mar 19, 2026
Maintains: Buy
Price Target: $2 → $2.5
Current: $1.76
Upside: +42.05%
Tandem Diabetes Care
Feb 23, 2026
Upgrades: Buy
Price Target: $50
Current: $14.77
Upside: +238.64%
Inotiv
Feb 10, 2026
Maintains: Buy
Price Target: $3 → $1.5
Current: $0.29
Upside: +410.90%
AVITA Medical
Jan 16, 2026
Maintains: Hold
Price Target: $3 → $3.5
Current: $4.37
Upside: -19.91%
Beta Bionics
Jan 9, 2026
Maintains: Buy
Price Target: $35 → $40
Current: $9.83
Upside: +306.92%
KORU Medical Systems
Dec 22, 2025
Maintains: Buy
Price Target: $6 → $8
Current: $4.01
Upside: +99.50%
Sight Sciences
Dec 10, 2025
Maintains: Buy
Price Target: $7 → $12
Current: $5.32
Upside: +125.78%
Dec 2, 2025
Initiates: Buy
Price Target: $4
Current: $0.95
Upside: +321.32%
Oct 28, 2025
Maintains: Buy
Price Target: $8 → $4
Current: $1.29
Upside: +210.08%
Sep 10, 2025
Maintains: Buy
Price Target: $8 → $6
Current: $1.05
Upside: +471.43%
Aug 5, 2025
Maintains: Buy
Price Target: $270 → $150
Current: $43.35
Upside: +246.02%
Jul 16, 2025
Initiates: Buy
Price Target: $24
Current: $10.83
Upside: +121.61%
Apr 8, 2025
Maintains: Buy
Price Target: $19 → $14
Current: $6.90
Upside: +102.90%
Mar 24, 2025
Downgrades: Hold
Price Target: $16 → $15
Current: $5.74
Upside: +161.32%
Feb 14, 2025
Maintains: Buy
Price Target: $17 → $26
Current: $13.02
Upside: +99.69%
Jan 21, 2025
Maintains: Buy
Price Target: $17 → $30
Current: $12.33
Upside: +143.31%
Jan 8, 2025
Initiates: Buy
Price Target: $20
Current: $6.52
Upside: +206.75%
Dec 11, 2024
Initiates: Buy
Price Target: $5
Current: $1.26
Upside: +296.83%
Jul 2, 2024
Maintains: Buy
Price Target: $28 → $30
Current: $23.78
Upside: +26.18%
Apr 3, 2024
Maintains: Buy
Price Target: $3 → $6
Current: $0.64
Upside: +831.68%
Mar 5, 2024
Maintains: Buy
Price Target: $3 → $4
Current: $1.87
Upside: +113.90%
Dec 27, 2023
Reiterates: Buy
Price Target: $12
Current: $15.64
Upside: -23.27%
Jun 15, 2023
Maintains: Buy
Price Target: $6 → $9
Current: $3.90
Upside: +130.77%
May 18, 2023
Maintains: Buy
Price Target: $14 → $16
Current: $4.17
Upside: +283.69%
Jan 18, 2023
Maintains: Buy
Price Target: $923 → $277
Current: $6.77
Upside: +3,990.10%